“Updates in Cholangiocarcinoma”

Friday, June 9, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first served basis

Presented by:

Kabir Mody, M.D.

Assistant Professor of Medicine

Senior Associate Consultant

Hematology/Oncology

Mayo Clinic Florida

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Understand current standard of care for cholangiocarcinoma.
• Understand the changing face of cholangiocarcinoma and the increasing potential options.
• Understand the rising incidence of cholangiocarcinoma.

  “Speaker, Doctor Kabir Mody, has noted financial relationship with Celgene and Genetech. He does not intend to discuss off-label/ investigational use of a commercial product device. Course Director, Doctor James Foran, has no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

   

  Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

   

  Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

   

  Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326)

  For further information, contact  Jen Gatchell 3-2795